COVERA AVSM09080Recalls & reported problems
Angiomed GmbH & Co. Medizintechnik KG · COVERA™ Vascular Covered Stent 9 mm x 80 mm (80 cm delivery catheter) (straight) · Class 3 · Implant
All models of COVERA (65)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 14
- Deaths reported
- 1
- Injuries reported
- 4
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 14 adverse event reports that list this exact device (DI 00801741106354), received between Jan 13, 2020 and Aug 18, 2025 — classified as 1 death, 4 injuries, 9 malfunctions.
The most frequently reported specific device problem is “Material Deformation” (5 reports).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Recalls naming this device
- Dec 22, 2022Open, Classified
An increase in the reported complaint rate for inability to deploy was identified and related to poor slide block bonding.
Z-1108-2023 · Root cause: Unknown/Undetermined by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Material Deformation5
- Adverse Event Without Identified Device or Use Problem4
- Positioning Failure3
- Break2
- Activation Failure1
- Device Damaged Prior to Receipt by User1
- Fracture1
- Insufficient Device Problem Information1
Patient problems
- No Clinical Signs, Symptoms or Conditions9
- Restenosis3
- Aneurysm1
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Insufficient Information1
- No Consequences Or Impact To Patient1
- Unspecified Tissue Injury1
Recent adverse event reports
The 14 most recent of 14 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 18, 2025Device Damaged Prior to Receipt by User; Device Damaged Prior to Receipt by User
A PATIENT PREPPED FOR A STENT GRAFT PLACEMENT PROCEDURE USING THE COVERA VASCULAR COVERED STENT. PRIOR TO THE PROCEDURE IT WAS FOUND THAT, THE DEVICE WAS ALLEGEDLY BENT IN HALF AND PACKAGING ISSUE WAS NOTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22824883 ↗MalfunctionJul 9, 2025Material Deformation; Material Deformation
IT WAS REPORTED THAT A 9X80 MM STENT WAS FOUND COLLAPSED ABOUT FOUR MONTHS AFTER PLACEMENT. THE 9X80 MM STENT HAD BEEN PLACED IN (B)(6) 2024 DUE TO A RUPTURE OF THE CEPHALIC ARCH AREA AND AN ELASTIC RECOIL OF A STENOSIS AFTER ANGIOPLASTY WITH AN 8X100 MM BALLOON TO TREAT A TIGHT RECURRENT STENOSIS IN THE CEPHALIC ARCH. JUST AFTER PLACEMENT OF THE STENT, THE CEPHALIC VEIN OF THE UPPER ARM BELOW THE CEPHALIC ARCH LOOKED STENOTIC, EVEN THOUGH IT HAD A GOOD SIZE PRIOR TO STENT PLACEMENT. POST DILATION DID NOT IMPROVE THE SITUATION. HOWEVER, THE VESSEL HAD A GOOD THRILL AND SOFT NORMAL PULSATION. FOUR MONTHS AFTER STENT PLACEMENT, THE PATIENT WAS SEEN DUE TO PROLONGED BLEEDING; THE 9X80 MM STENT WAS FOUND COLLAPSED AND THERE WAS NO FLOW THROUGH THE STENT. INITIALLY, THE PHYSICIAN WAS NOT ABLE TO PASS A GUIDE WIRE THROUGH THE STENT; AFTER PROLONGED MANIPULATION, A GUIDE WIRE COULD BE ADVANCED THROUGH THE STENT AND AN ADDITIONAL STENT, A 12X40 MM STENT OF A DIFFERENT BRAND, WAS PLACED WITHIN THE COLLAPSED 9X80 MM STENT. ANOTHER SEVEN WEEKS LATER, THE AREA OF THE 9X80 MM STENT, WHICH WAS NOT EXPANDED BY THE 12X40 MM STENT, WAS FOUND COMPRESSED AS WELL. AN ADDITIONAL 13X100 MM STENT OF ANOT
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22456870 ↗MalfunctionJun 3, 2025Material Deformation; Material Deformation
ON 8 MAY 2025, A PATIENT UNDERWENT A STENT GRAFT PLACEMENT PROCEDURE USING THE COVERA VASCULAR COVERED STENT IN THE THROMBOSIS OF THE LEFT ARM BASILIC VEIN. UPON DEPLOYMENT OF THE COVERA, A NOTICEABLE CLICK WAS HEARD DURING DEPLOYMENT, CAUSING THE STENT TO JUMP CENTRALLY ABOUT A MILLIMETER OR TWO. ONCE DEPLOYED, THE STENT WAS POST DIALATED WITH THE SAME 9X40 BIOTRONIK PASEO BALLOON. AFTER CHECKING WITH FLUORO, THE PHYSICIAN DECIDED TO ULTRASOUND THE STENTED SEGMENTED, AND IT WAS THEN NOTICED THAT THE STENT HAS COLLAPSED, INTRASTENT PROXIMALLY TO THE END OF THE NEWLY PLACED COVERA. THE PHYSICIAN CHECKED THE THRILL AND NOTICED THE ACCESS FEELING PULSATILE. SHE WENT BACK TO ANGIOPLASTY THAT AFFECTED AREA WITH THE SAME 9X40 BIOTRONIK PASEO BALLOON TO OPEN THE COLLAPSED AREA. ANOTHER DEVICE WAS USED TO COMPLETE THE PROCEDURE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22130494 ↗MalfunctionAug 21, 2024Fracture; Material Deformation; Fracture; Material Deformation
IT WAS REPORTED THAT APPROXIMATELY SOMETIME POST STENT GRAFT PLACEMENT PROCEDURE, THE STENT ALLEGEDLY COMPRESSED AFTER IT WAS DEPLOYED. IT WAS FURTHER REPORTED THAT THE STENT WAS FRACTURED. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20010611 ↗InjuryApr 15, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THROUGH THE RESULTS OF A CLINICAL TRIAL THAT TWO YEARS, FIVE MONTHS AND THIRTEEN DAYS POST A STENT GRAFT PLACEMENT IN THE CEPHALIC VEIN AT CEPHALIC VEIN ARCH VIA THE LEFT UPPER ARM, THE SUBJECT DEVELOPED CEPHALIC VEIN RESTENOSIS WHICH REQUIRED AN ARTERIOVENOUS ACCESS CIRCUIT REINTERVENTION DUE TO PULSATILITY AND ANEURYSMATIC FISTULA. IT WAS FURTHER REPORTED THAT STANDARD PERCUTANEOUS TRANSLUMINAL BALLOON ANGIOPLASTY PROCEDURE WAS PERFORMED TO TREAT PULSATILITY AND ANEURYSMATIC FISTULA. TREATMENT REINTERVENTION WAS SUCCESSFUL, NO NEW ACCESS CREATED AND THE OUTCOME OF ARTERIOVENOUS ACCESS CIRCUIT REINTERVENTION WAS RESOLVED. THE CURRENT STATUS OF THE PATIENT IS UNKNOWN.
Patient problems: Restenosis
MAUDE report 19104511 ↗MalfunctionDec 18, 2023Break; Positioning Failure; Break; Positioning Failure
IT WAS REPORTED THAT DURING A STENT GRAFT PLACEMENT PROCEDURE, THE STENT ALLEGEDLY FAILED TO DEPLOY. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18343156 ↗MalfunctionJun 15, 2023Positioning Failure; Positioning Failure
IT WAS REPORTED THAT DURING A STENT PLACEMENT PROCEDURE, STENT ALLEGEDLY DID NOT OPEN. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17133075 ↗InjuryDec 10, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THROUGH THE RESULTS OF A CLINICAL TRIAL, THAT APPROXIMATELY ONE YEAR AND FOUR DAYS POST INDEX PROCEDURE, THE SUBJECT DEVELOPED SEVENTY PERCENT OF STENOSIS. STANDARD PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) WAS USED TO SUCCESSFULLY TREAT THE TARGET LESION. THE CURRENT PATIENT STATUS IS NOT PROVIDED.
Patient problems: Restenosis
MAUDE report 15956042 ↗MalfunctionJan 9, 2022Loss of or Failure to Bond; Misfire; Loss of or Failure to Bond; Misfire
IT WAS REPORTED THAT DURING A STENT PLACEMENT PROCEDURE, THE DEVICE ALLEGEDLY DEPLOYED PARTIALLY. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13201029 ↗InjuryNov 8, 2021Migration or Expulsion of Device; Obstruction of Flow; Material Twisted/Bent; Adverse Event Without Identified Device or Use Problem; Migration or Expulsion of Device; Obstruction of Flow; Material Twisted/Bent; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THROUGH THE RESULTS OF A CLINICAL TRIAL, THAT APPROXIMATELY FORTY FIVE DAYS POST INDEX PROCEDURE, THE PATIENT DEVELOPED SEVENTY PERCENTAGE OF TARGET LESION STENOSIS. A STANDARD PTA WAS USED TO SUCCESSFULLY TREAT THE TARGET LESION. THE CURRENT PATIENT STATUS WAS NOT PROVIDED.
Patient problems: Aneurysm; Restenosis; Unspecified Tissue Injury
MAUDE report 12769791 ↗DeathOct 5, 2021Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
IT WAS REPORTED THROUGH THE RESULTS OF A CLINICAL TRIAL, THAT APPROXIMATELY THREE MONTHS POST INDEX PROCEDURE, THE PATIENT WAS EXPIRED. THE DEATH WAS NOT RELATED TO THE STUDY DEVICE.
Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions
MAUDE report 12574069 ↗InjuryFeb 12, 2021Material Deformation; Material Deformation
IT WAS REPORTED THAT APPROXIMATELY THREE MONTHS POST STENT PLACEMENT PROCEDURE, THE STENT ALLEGEDLY FOLDED COMPLETELY ON ONE END. IT WAS FURTHER REPORTED THAT A PIECE OF GRAFT WAS SUTURED FROM VEIN TO THE STENT TO REPAIR THE FISTULA. THE PATIENT CURRENT STATUS WAS UNKNOWN.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
MAUDE report 11320479 ↗MalfunctionJan 18, 2021Break; Positioning Failure; Break; Positioning Failure
IT WAS REPORTED THAT DURING STENT GRAFT PLACEMENT PROCEDURE, THE STENT ALLEGEDLY FAILED TO DEPLOY. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11184352 ↗MalfunctionJan 13, 2020Material Deformation; Activation Failure; Material Deformation; Activation Failure
THIS REPORT SUMMARIZES ONE (1) MALFUNCTION. A REVIEW OF THE REPORTED MALFUNCTION INDICATED THAT MODEL AVSM09080 VASCULAR COVERED STENT ALLEGEDLY FAILED TO EXPAND. THIS REPORT WAS RECEIVED FROM ONE SOURCE. THIS MALFUNCTION INVOLVED A PATIENT WITH NO PATIENT CONSEQUENCES. THE PATIENT WAS A (B)(6) YEAR OLD FEMALE WEIGHING (B)(6) LBS.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9583526 ↗
Other System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment devices
- COVERA AVSM10060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall33 reports
- COVERA AVSM08060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall21 reports
- COVERA AVSM09060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall18 reports
- COVERA AVSM10080Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall16 reports
- COVERA AVSM10040Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall15 reports
- COVERA AVFM10060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall14 reports
- COVERA AVSM10100Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall13 reports
- COVERA AVFM09060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall12 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page